| 1 |
35174317 | MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma. | 2022 Feb |
1 |
| 2 |
33918978 | A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma. | 2021 Apr 9 |
1 |
| 3 |
34129075 | Probenecid increases renal retention and antitumor activity of DFMO in neuroblastoma. | 2021 Oct |
1 |
| 4 |
32786875 | Allicin, a Potent New Ornithine Decarboxylase Inhibitor in Neuroblastoma Cells. | 2020 Aug 28 |
1 |
| 5 |
25593318 | Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells. | 2015 Mar 6 |
2 |
| 6 |
26835380 | Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma. | 2015 Jul |
1 |
| 7 |
25426416 | MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines. | 2014 |
2 |
| 8 |
23440295 | DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma. | 2013 Apr |
1 |
| 9 |
23457004 | AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport. | 2013 Sep 15 |
1 |
| 10 |
19960435 | The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification. | 2010 May 1 |
1 |
| 11 |
19147568 | Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma. | 2009 Jan 15 |
1 |
| 12 |
19584241 | Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma. | 2009 Jul |
1 |
| 13 |
16007177 | Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells. | 2005 Aug 25 |
2 |